GI Innovation Seen Nearing Licensing Deal Within Year
9h agoen
Source
Seoul Economic DailyGI Innovation Seen Nearing Licensing Deal Within Yearsedaily.comGI Innovation is expected to sign a technology transfer deal within the year, as its GI-101A cancer drug showed a 55% ORR and its GI-102 program advances with J&J.
You might also wanna read
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
ft.trib.al·29d ago
GE HealthCare Unveils AI and Radiopharmaceutical Innovations to Expand Nuclear Medicine Access at SNMMI 2026
GE HealthCare is showcasing new AI-enabled workflows, radiopharmaceuticals, and imaging innovations at the 2026 SNMMI Annual Meeting to help
stocktitan.net·1mo ago
Mayo Clinic aligns Berg Innovation Exchange with Business Development to accelerate healthcare innovation
Mayo Clinic is strengthening its healthcare innovation ecosystem by aligning the Mayo Clinic Berg Innovation Exchange with Mayo Clinic Busin
mayocl.in·7d ago
LG Chem partners with China's OTR to develop cancer drugs
The Korea Herald·6h ago
Takeda signs $600M AI drug discovery deal with Insilico
artificialintelligence-news.com·4d ago
Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
The Daily Upside·12d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.